Actively Recruiting
Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy
Led by Tanta University · Updated on 2026-01-16
96
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare the efficacy of using oral Melatonin versus nebulized Dexmedetomidine in limitation of emergence agitation in children undergoing adenotonsillectomy.
CONDITIONS
Official Title
Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged between 3 and 7 years
- Both sexes
- Classified as American Society of Anesthesiologists (ASA) physical status I or II
- Scheduled for elective adenotonsillectomy under general anesthesia
You will not qualify if you...
- Parental refusal to participate in the study
- Known allergy or hypersensitivity to dexmedetomidine, melatonin or midazolam
- Presence of developmental delay
- Central nervous system disorders
- Intellectual disability
- Neurological or psychiatric conditions associated with anxiety or agitation such as cerebral palsy, epilepsy, separation anxiety disorder, or attention-deficit/hyperactivity disorder
- Current or recent treatment with anticonvulsants or sedative medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527
Actively Recruiting
Research Team
A
Amany A Eid, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here